Katerina T. Xenaki

Antibody or Antibody Fragments: Implications for Molecular Imaging and Targeted Therapy of Solid Tumors

Katerina T. Xenaki, Sabrina Oliveira, Paul M.P. van Bergen en Henegouwen · Frontiers in Immunology · 2017 · 274 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +17

Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice

Katerina T. Xenaki, Bram Dorresteijn, Joey A. Muns et al. · Theranostics · 2021 · 81 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Imaging of Tumor Spheroids, Dual-Isotope SPECT, and Autoradiographic Analysis to Assess the Tumor Uptake and Distribution of Different Nanobodies

Irati Beltrán Hernández, Rene Rompen, Raffaella Rossin et al. · Molecular Imaging and Biology · 2019 · 34 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Implications for tetraspanin-enriched microdomain assembly based on structures of CD9 with EWI-F

Wout Oosterheert, Katerina T. Xenaki, Viviana Neviani et al. · Life Science Alliance · 2020 · 33 citations · Full text

Life Sciences, Biology, Molecular Biology +17

Dual Targeting of Endothelial and Cancer Cells Potentiates In Vitro Nanobody-Targeted Photodynamic Therapy

Vida Mashayekhi, Katerina T. Xenaki, Paul M.P. van Bergen en Henegouwen et al. · Cancers · 2020 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17